EliLilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P500's daily gain of 1.1%. Elsewhere ...
EliLilly's operational performance is strong ... shares have seen downside of 14.8% at a time when the S&P500 is up 2.6%. The picture isn't as bad when we compare the data to my original ...
EliLilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers for Medicare and Medicaid ...
big The S&P500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's consumer price report. EliLilly can’t seem to recover from its ...